BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15108291)

  • 1. OCRL mutation analysis in Italian patients with Lowe syndrome.
    Addis M; Loi M; Lepiani C; Cau M; Melis MA
    Hum Mutat; 2004 May; 23(5):524-5. PubMed ID: 15108291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCRL1 mutation analysis in French Lowe syndrome patients: implications for molecular diagnosis strategy and genetic counseling.
    Monnier N; Satre V; Lerouge E; Berthoin F; Lunardi J
    Hum Mutat; 2000; 16(2):157-65. PubMed ID: 10923037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of OCRL1 mutations in two Taiwanese Lowe syndrome patients.
    Chou YY; Chao SC; Chiou YY; Lin SJ
    Acta Paediatr Taiwan; 2005; 46(4):226-9. PubMed ID: 16381338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.
    Röschinger W; Muntau AC; Rudolph G; Roscher AA; Kammerer S
    Mol Genet Metab; 2000 Mar; 69(3):213-22. PubMed ID: 10767176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients.
    Lin T; Orrison BM; Suchy SF; Lewis RA; Nussbaum RL
    Mol Genet Metab; 1998 May; 64(1):58-61. PubMed ID: 9682219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel OCRL mutations in Chinese children with Lowe syndrome.
    Zhang YQ; Wang F; Ding J; Yan H; Yang YL
    World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
    Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
    Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowe syndrome - Case report with a novel mutation in the oculocerebrorenal gene.
    Sethi S; Sethi N; Mehta S; Kaur S; Makkar V; Sohal PM
    Saudi J Kidney Dis Transpl; 2020; 31(1):285-288. PubMed ID: 32129227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel OCRL1 gene mutation in a Turkish child with Lowe syndrome.
    Kanık A; Kasap-Demir B; Ateşli R; Eliaçık K; Yavaşcan O; Helvacı M
    Turk J Pediatr; 2013; 55(1):82-5. PubMed ID: 23692838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two novel mutations in the OCRL1 gene in Japanese families with Lowe syndrome.
    Kubota T; Sakurai A; Arakawa K; Shimazu M; Wakui K; Furihata K; Fukushima Y
    Clin Genet; 1998 Sep; 54(3):199-202. PubMed ID: 9788721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.
    Lin T; Orrison BM; Leahey AM; Suchy SF; Bernard DJ; Lewis RA; Nussbaum RL
    Am J Hum Genet; 1997 Jun; 60(6):1384-8. PubMed ID: 9199559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation and OCRL mutation analysis of a family with oculocerebrorenal syndrome of Lowe].
    Shi RM; Bian XH; Li LM; Liu XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):366-9. PubMed ID: 24750831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in OCRL1 gene in Indian children with Lowe syndrome.
    Sethi SK; Bagga A; Gulati A; Hari P; Gupta N; Lunardi J
    Clin Exp Nephrol; 2008 Oct; 12(5):358-362. PubMed ID: 18500547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel interstitial deletion in Xq25, identified by array-CGH in a patient with Lowe syndrome.
    Addis M; Meloni C; Congiu R; Santaniello S; Emma F; Zuffardi O; Ciccone R; Cao A; Melis MA; Cau M
    Eur J Med Genet; 2007; 50(1):79-84. PubMed ID: 17142121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.
    Recker F; Zaniew M; Böckenhauer D; Miglietti N; Bökenkamp A; Moczulska A; Rogowska-Kalisz A; Laube G; Said-Conti V; Kasap-Demir B; Niemirska A; Litwin M; Siteń G; Chrzanowska KH; Krajewska-Walasek M; Sethi SK; Tasic V; Anglani F; Addis M; Wasilewska A; Szczepańska M; Pawlaczyk K; Sikora P; Ludwig M
    Pediatr Nephrol; 2015 Jun; 30(6):931-43. PubMed ID: 25480730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome.
    Zheng B; Chen Q; Wang C; Zhou W; Chen Y; Ding G; Jia Z; Zhang A; Huang S
    Mol Genet Genomic Med; 2019 Sep; 7(9):e876. PubMed ID: 31376231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene.
    Satre V; Monnier N; Berthoin F; Ayuso C; Joannard A; Jouk PS; Lopez-Pajares I; Megabarne A; Philippe HJ; Plauchu H; Torres ML; Lunardi J
    Am J Hum Genet; 1999 Jul; 65(1):68-76. PubMed ID: 10364518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase.
    Attree O; Olivos IM; Okabe I; Bailey LC; Nelson DL; Lewis RA; McInnes RR; Nussbaum RL
    Nature; 1992 Jul; 358(6383):239-42. PubMed ID: 1321346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe.
    Leahey AM; Charnas LR; Nussbaum RL
    Hum Mol Genet; 1993 Apr; 2(4):461-3. PubMed ID: 8504307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and functional characterization of a hemizygous novel intronic variant in OCRL gene causes Lowe syndrome.
    Sun J; Zhou Z; Weng C; Wang C; Chen J; Feng X; Yu P; Qi M
    Clin Exp Nephrol; 2020 Aug; 24(8):657-665. PubMed ID: 32394213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.